The Frequency of Malignant Neoplasms in Patients With Polymyositis-Dermatomyositis: A Controlled Study

Archives of Internal Medicine

Volumn 145, Issue 10, 1985, Pages 1835-1839

  Manchul, Lee A ^a   Jin, Andrew ^a   Pritchard, Kathleen I ^a,c   Tenenbaum, Jerry ^a   Boyd, Norman F ^b   Lee, Peter ^a   Germanson, Teresa ^b   Gordon, Duncan A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c Ontario Cancer Institute ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER INCIDENCE; CANCER RISK; CLINICAL ARTICLE; DERMATOMYOSITIS; EPIDEMIOLOGY; HUMAN; MUSCLE; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE;

ADOLESCENT; ADULT; AGED; DERMATOMYOSITIS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOSITIS; NEOPLASMS; RHEUMATIC DISEASES; TIME FACTORS;

EID: 84941813441     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1985.00360100097016     Document Type: Article

References (22)

1. Johnson M-L: Cutaneous manifestations of internal malignancy, in Wyngaarden JB, Smith LH (eds): Cecil Textbook of Medicine. Philadelphia, WB Saunders Co, 1982, p 1031.
2. Ryan TJ: Diseases of the skin, in Weatherall DJ, Ledingham JGG, Warrell DA (eds): Oxford Textbook of Medicine. Oxford, England, Oxford University Press, 1983, sect 20, p 84.
3. Bradley WG, Salam-Adams M: Acute and subacute myopathic paralysis, in Petersdorf RG, Adams RD, Braunwald E, et al (eds): Harrison’s Principles of Internal Medicine. New York, McGraw-Hill Book Co, 1983, p 2185.
4. Bohan A, Peter JB: Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-347, 403-407.
5. Rose AL, Walton JN: Polymyositis: A survey of 89 cases with particular reference to treatment and prognosis. Brain 1966;89:747-768.
6. Arundell FD, Wilkinson RD, Haserick JR: Dermatomyositis and malignant neoplasms in adults. Arch Dermatol 1960;82:772-775.
7. Williams RC Jr: Dermatomyositis and malignancy: A review of the literature. Ann Intern Med 1959;50:1174-1181.
8. Christianson HB, Brunsting LA, Perry HO: Dermatomyositis: Unusual features, complications and treatment. Arch Dermatol 1956;74: 581-589.
9. Talbott JH: Acute dermatomyositis-polymyositis and malignancy. Semin Arthritis Rheum 1977;6:305-360.
10. Callen JP, Hyla JF, Bole GG, et al: The relationship of dermatomyositis and polymositis to internal malignancy. Arch Dermatol 1980;116:295-298.
11. Ogle S: Retrospective study of polymyositis in Auckland over ten years. NZ Med J 1980;92:433-435.
12. Vesterage L, Worm A-M, Thomsen K: Dermatomyositis and malignancy. Clin Exp Dermatol 1980;5:31-35.
13. Barnes BE: Dermatomyositis and malignancy: A review of the literature. Ann Intern Med 1976;84:68-76.
14. Moss AA, Hanelin LG: Occult malignant tumours in dermatologic disease. Radiology 1977;123:69-71.
15. Feinstein AR: Clinical biostatistics: XI. Sources of chronology bias in cohort statistics. Clin Pharmacol Ther 1971;12:864.
16. Cancer in Canada. Ottawa, Ontario, Statistics Canada, 1976, p 3.
17. Fleiss JL: Statistical Methods for Rates and Proportions. New York, John Wiley & Sons Inc, 1973, p 272.
18. Woolf B: On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251-253.
19. Miller RG: Parametric models, in Survival Analysis. New York, John Wiley & Sons Inc, 1981, chap 2, sect 2, pp 24-25.
20. Shy GM: The late onset myopathy: A clinicopathologic study of 131 patients. World Neurol 1962;3:149-160.
21. Schlesselman JJ: Case Control Studies: Design, Conduct Analysis. Oxford, England, Oxford University Press, 1982.
22. Callan JP: The value of malignancy evaluation in patients with dermatomyositis. Am Acad Dermatol 1982;6:253-259.